Agilent Technologies 

€110.85
527
+€2.40+2.21% Friday 07:15

Statistics

Day High
110.85
Day Low
110.8
52W High
137.68
52W Low
94.65
Volume
0
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
0.8%
Dividend
0.89

Upcoming

Dividends

0.8%Dividend Yield
Jul 26
€0.22
Apr 26
€0.22
Jan 26
€0.22
Oct 25
€0.21
Jul 25
€0.21
10Y Growth
7.41%
5Y Growth
6.23%
3Y Growth
1.65%
1Y Growth
35.65%

Earnings

18AugExpected
Q4 2025
Q1 2026
Next
1.15
1.2
1.25
1.3
Expected EPS
1.29973485739
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AG8.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap174.42B
AmericaTowne Holdings, Inc., headquartered in Raleigh, North Carolina, specializes in designing and exporting cutting-edge modular energy-efficient technologies and processes. These innovations are deployed to construct adaptable spaces, facilities, and properties throughout China, catering to both governmental bodies and private sector organizations.
Danaher
DHR
Mkt Cap127.47B
Danaher Corporation operates in similar segments as Agilent, including life sciences, diagnostics, and environmental and applied solutions, competing directly in multiple product lines.
Waters
WAT
Mkt Cap34.91B
Waters Corporation specializes in analytical instruments for liquid chromatography, mass spectrometry, and thermal analysis, competing in key areas of Agilent's business.
Bruker
BRKR
Mkt Cap8.26B
Bruker Corporation offers a range of scientific instruments and analytical solutions, directly competing with Agilent in the life science research and diagnostics fields.
Bio-Rad Laboratories
BIO
Mkt Cap7.65B
Bio-Rad Laboratories, Inc. provides instruments and consumables in the life science research and clinical diagnostics markets, competing with Agilent's offerings.
Agilent Technologies
A
Mkt Cap36.67B
Alcoa Corporation stands as a global industrial leader, primarily focused on the production and sale of bauxite, alumina, and aluminum products. Its extensive operations span multiple continents, including North America (United States, Canada), Europe (Spain, Iceland, Norway), South America (Brazil), and Australia, along with other international markets. The company's activities are strategically divided into three principal segments: Bauxite, Alumina, and Aluminum. Alcoa initiates its process with bauxite mining. This raw material is then refined into alumina, which is subsequently sold to customers for conversion into various industrial chemical products. Additionally, the company is involved in aluminum smelting and casting, supplying primary aluminum in forms like alloy or value-added ingots. These aluminum products cater to a diverse range of industries, including transportation, building and construction, packaging, wire manufacturing, and other industrial applications. Beyond its core metals business, Alcoa also operates hydroelectric power generation facilities. These plants generate and sell electricity into the wholesale market, serving a wide array of clients, from traders and large industrial consumers to distribution companies and other power generators. Founded in 1888, the company is headquartered in Pittsburgh, Pennsylvania. It officially adopted the name Alcoa Corporation in October 2016, prior to which it was known as Alcoa Upstream Corporation.
Mettler-Toledo International
MTD
Mkt Cap22.86B
AMTD IDEA Group functions as an investment holding company, primarily engaged in investment banking operations across various global regions, including Hong Kong, Mainland China, and the United States. The company structures its diverse business activities into three main divisions: Investment Banking, Asset Management, and Strategic Investment. Within its Investment Banking segment, AMTD IDEA Group provides a comprehensive range of services. These include facilitating equity and debt underwriting, securities brokerage, institutional sales and distribution, and research. Furthermore, it offers expert advisory services related to credit ratings, corporate financing, and mergers and acquisitions (M&A) transactions. The company's Asset Management division specializes in delivering professional investment management and advisory services, primarily catering to corporate and other institutional clients. Additionally, its Strategic Investment arm focuses on making long-term capital deployments, specifically targeting emerging financial and new economy sectors within Asia. AMTD IDEA Group was established in 2019 and maintains its headquarters in Central, Hong Kong. Previously operating as AMTD International Inc., it currently functions as a subsidiary under the umbrella of AMTD Group Company Limited.
Resmed
RMD
Mkt Cap28.25B
ResMed Inc. operates in the medical equipment and devices sector, indirectly competing with Agilent in the broader healthcare and diagnostics market.
Illumina
ILMN
Mkt Cap24.35B
Illumina, Inc. specializes in genomics and sequencing solutions, competing with Agilent in the genomics and molecular diagnostics segments.

About

Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.
Show more...
CEO
Country
United States
ISIN
US00846U1016

Listings

0 Comments

Share your thoughts

FAQ

What is Agilent Technologies stock price today?
The current price of AG8.MU is €110.85 EUR — it has increased by +2.21% in the past 24 hours. Watch Agilent Technologies stock price performance more closely on the chart.
What is Agilent Technologies stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Agilent Technologies stocks are traded under the ticker AG8.MU.
Is Agilent Technologies stock price growing?
AG8.MU stock has fallen by -1.69% compared to the previous week, the month change is a +11.82% rise, over the last year Agilent Technologies has showed a +11.05% increase.
When is the next Agilent Technologies earnings date?
Agilent Technologies is going to release the next earnings report on August 18, 2026.
What were Agilent Technologies earnings last quarter?
AG8.MU earnings for the last quarter are 1.28 EUR per share, whereas the estimation was 1.21 EUR resulting in a +5.79% surprise. The estimated earnings for the next quarter are N/A EUR per share.
Does Agilent Technologies pay dividends?
Yes, AG8.MU dividends are paid quarterly. The last dividend per share was 0.22 EUR. As of today, Dividend Yield (FWD)% is 0.8%.
In which sector is Agilent Technologies located?
Agilent Technologies operates in the Materials sector.
When did Agilent Technologies complete a stock split?
The last stock split for Agilent Technologies was on November 03, 2014 with a ratio of 1398:1000.